irofulven has been researched along with rubitecan in 1 studies
Studies (irofulven) | Trials (irofulven) | Recent Studies (post-2010) (irofulven) | Studies (rubitecan) | Trials (rubitecan) | Recent Studies (post-2010) (rubitecan) |
---|---|---|---|---|---|
99 | 22 | 7 | 149 | 34 | 22 |
Protein | Taxonomy | irofulven (IC50) | rubitecan (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 5.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kulke, MH | 1 |
1 review(s) available for irofulven and rubitecan
Article | Year |
---|---|
Advanced pancreatic cancer: is there a role for combination therapy?
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cysteine Endopeptidases; Deoxycytidine; Fluorouracil; Gemcitabine; Genes, ras; Glutamates; Guanine; Humans; Multienzyme Complexes; Pancreatic Neoplasms; Pemetrexed; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein-Tyrosine Kinases; Sesquiterpenes | 2003 |